Adaptive evolution of the Bordetella autotransporter pertactin

被引:10
作者
Diavatopoulos, D. A.
Hijnen, M.
Mooi, F. R. [1 ]
机构
[1] Natl Inst Publ Hlth & Environm, Lab Vaccine Preventable Dis, Antoine Van Leeuwenhoeklaan 1,POB 1, NL-3720 BA Bilthoven, Netherlands
[2] Univ Utrecht, Med Ctr, Eijkman Winkler Inst, Utrecht, Netherlands
关键词
Bordetella; epitope polymorphism; immune evasion; nucleotide substitution; pertactin; positive selection;
D O I
10.1111/j.1420-9101.2006.01154.x
中图分类号
Q14 [生态学(生物生态学)];
学科分类号
071012 ; 0713 ;
摘要
The virulence factor pertactin is expressed by the closely related pathogens Bordetella pertussis, Bordetella parapertussis and Bordetella bronchiseptica. Pertactin is an autotransporter involved in adherence of Bordetella species to the lung epithelium of mammalian hosts, and it is an important component of most current acellular pertussis vaccines. These three species produce immunologically distinct pertactin molecules, resulting in a lack of cross-protection against B. parapertussis and probably also against B. bronchiseptica. Variation in pertactin is not only inter-specific, but also occurs between isolates from the same species. Knowledge about codons that are under positive selection could facilitate the development of more broadly protective vaccines. Using different nucleotide substitution models, pertactin genes from B. bronchiseptica, B. parapertussis and B. pertussis were compared, and positively selected codons were identified using an empirical Bayesian approach. This approach yielded 15 codons predicted to be under diversifying selection pressure. These results were interpreted in an immunological context and may help in improving future pertussis vaccines.
引用
收藏
页码:1931 / 1938
页数:8
相关论文
共 35 条
[1]   The Protein Data Bank [J].
Berman, HM ;
Westbrook, J ;
Feng, Z ;
Gilliland, G ;
Bhat, TN ;
Weissig, H ;
Shindyalov, IN ;
Bourne, PE .
NUCLEIC ACIDS RESEARCH, 2000, 28 (01) :235-242
[2]   Resurgence of pertussis in Europe [J].
Celentano, LP ;
Massari, M ;
Paramatti, D ;
Salmaso, S ;
Tozzi, AE .
PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2005, 24 (09) :761-765
[3]   A search for serologic correlates of immunity to Bordetella pertussis cough illnesses [J].
Cherry, JD ;
Gornbein, J ;
Heininger, U ;
Stehr, K .
VACCINE, 1998, 16 (20) :1901-1906
[4]   Efficacies of whole cell and acellular pertussis vaccines against Bordetella parapertussis in a mouse model [J].
David, S ;
van Furth, R ;
Mooi, FR .
VACCINE, 2004, 22 (15-16) :1892-1898
[5]   Bordetella pertussis, the causative agent of whooping cough, evolved from a distinct, human-associated lineage of B-bronchiseptica [J].
Diavatopoulos, Dimitri A. ;
Cummings, Craig A. ;
Schouls, Leo M. ;
Brinig, Mary M. ;
Relman, David A. ;
Mooi, Frits R. .
PLOS PATHOGENS, 2005, 1 (04) :373-383
[6]   Structure of Bordetella pertussis virulence factor P.69 pertactin [J].
Emsley, P ;
Charles, IG ;
Fairweather, NF ;
Isaacs, NW .
NATURE, 1996, 381 (6577) :90-92
[7]   Role of the Bordetella pertussis P.69/pertactin protein and the P.69/pertactin RGD motif in the adherence to and invasion of mammalian cells [J].
Everest, P ;
Li, JL ;
Douce, G ;
Charles, I ;
DeAzavedo, J ;
Chatfield, S ;
Dougan, G ;
Roberts, M .
MICROBIOLOGY-SGM, 1996, 142 :3261-3268
[8]  
Fraczkiewicz R, 1998, J COMPUT CHEM, V19, P319, DOI 10.1002/(SICI)1096-987X(199802)19:3<319::AID-JCC6>3.0.CO
[9]  
2-W
[10]   A controlled trial of a two-component acellular, a five-component acellular, and a whole-cell pertussis vaccine [J].
Gustafsson, L ;
Hallander, HO ;
Olin, P ;
Reizenstein, E ;
Storsaeter, J .
NEW ENGLAND JOURNAL OF MEDICINE, 1996, 334 (06) :349-355